Stephen Caddick,
Vice Provost for Enterprise,
University College London
Professor Caddick was appointed as Vice-Provost (Enterprise) in 2010, and is responsible for leading UCL's enterprise agenda including: knowledge transfer and exchange, business relationships and partnerships, entrepreneurship, innovation and social enterprise. He joined UCL in 2003 as Vernon Professor of Organic Chemistry and Chemical Biology. He was the founding director of the UCL Centre for Chemical Biology, and, from 2008-2010 served as Head of the Department of Chemistry. Professor Caddick has a major research group in Organic Synthesis and Chemical Biology with a particular focus on the development of novel and sustainable synthetic methods for applications in biological and biomedical research. He has served on a number of EPSRC, BBSRC and MRC funding panels and committees and is currently a member of MRCT's Drug Discovery Advisory Board. He has played key role in developing the unique contribution UCL will make to the Francis Crick Institute (formerly UKCMRI), which will bring the university together with Cancer Research UK, the Medical Research Council and the Wellcome Trust in a new institute in central London to undertake cutting-edge research and training of medical scientists to advance our understanding of health and disease. He is Chairman of the Bloomsbury Bioseed Fund and a Non-Executive director of UCL Business. He was founder of the open access publishing website SyntheticPages and a founder of biotech spin-out Thiologics. Professor Caddick served on the Review Panel of the Wilson Review of Business-University Collaboration, released in early 2012.
|
|
|